|
Cadre Holdings, Inc. (CDRE)
|
86 % |
|
Expanding access to essential medicines | Amneal Pharmaceuticals
Amneal is a U.S.-based biopharmaceutical company. We are expanding access to safe, effective and affordable medicines.
|
85 % |
|
Propanc Biopharma, Inc. (PPCB)
|
85 % |
|
Home - ADARx Pharmaceuticals
Amplifying Science Leveraging our decades of siRNA drug development experience and proprietary technologies, we are focused on developing next-generation siR...
|
85 % |
|
FOXO Technologies, Inc. (FOXOD)
|
85 % |
|
Nuvation Bio, Inc. | Oncology Drug Development
Discover Nuvation Bio, Inc., a leader in oncology drug development. Learn about our innovative pipeline and commitment to transforming cancer treatment.
|
85 % |
|
Enliven Therapeutics | Small Molecule Kinase Inhibitors
We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and...
|
85 % |
|
Cellectis | In vivo gene editing
Cellectis is pioneering gene surgery through in vivo gene editing technologies to create a new generation of genetic medicines.
|
84 % |
|
OSI Systems
OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in homeland...
|
84 % |
|
Home
Home
|
84 % |
|
Herantis Pharma - Innovative therapies for better lives
Herantis Pharma is a publicly listed drug development company aiming to revolutionize the treatment of diseases with unmet clinical needs.
|
84 % |
|
Roivant
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneuria...
|
84 % |
|
Captor Therapeutics
Captor Therapeutics is a high-tech pharmaceutical company focused on targeting the undruggable proteome.
|
84 % |
|
Activating the full potential of therapeutic botulinum toxin | AEON Biopharma
AEON is developing ABP-450, a proprietary botulinum toxin, to unlock the promise of therapeutic botulinum toxin to treat nervous system-related conditions
|
84 % |
|
Scilex Holding – Striving to Revolutionize the World of Pain Management
|
84 % |
|
Embracing Future Holdings Limited - Home
|
84 % |
|
SRX Global Inc. (SRXH)
SRX Global is building an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, st...
|
84 % |
|
Clinical-stage Biopharmaceutical Company | Biohaven
Harnessing the boundless potential of scientific innovation to transform the treatment of neurological and neuropsychiatric diseases.
|
83 % |
|
Home - CSW Industrials
|
83 % |
|
OPKO Health, Inc. (OPK)
|
83 % |
Detected social media networks